Abstract
Amyotrophic lateral sclerosis (ALS) is characterised by the aggregation of TDP-43 and mutant FUS in the cytoplasm of affected motor neurons. Accumulation of DNA damage is emerging as a novel correlative trait of ALS. We recently showed that formation of TDP-43 and FUS cytoplasmic inclusions (CIs) lead to DNA damage accumulation through dysregulation of the DNA damage response (DDR). However, the multiple molecular mechanisms contributing to DNA damage accumulation in affected motor neurons in ALS have not been fully elucidated. In recent years, chemical inhibition of the serine/threonine kinase CHK1 was shown to lead to accumulation of DNA breaks as well as increased apoptosis, in differentiated cortical neurons. Notably, CHK1 has been involved in DNA double-strand break repair in non-dividing cells, by acting through the histone chaperone ASF1A. In this article, we show that cells bearing FUS and TDP-43 CIs show downregulation of the protein levels of CHK1 and ASF1A. We observe CHK1 protein downregulation in neuronal cell lines, as well as in patient-derived motor neurons progenitors and in the spinal cord of a FUS-ALS mouse model. Restoration of the nuclear levels of CHK1 and ASF1A via transient overexpression, is sufficient to reduce DNA damage signal accumulation and rescues DDR defects. Importantly, we show that the ubiquitin-proteasome pathway is responsible for CHK1 degradation in cells bearing FUS CI, since its inhibition restores CHK1 and ASF1A protein levels. Our study demonstrates that proteasomal-dependent CHK1 and ASF1A downregulation contributes to accumulation of DNA damage in cells affected by ALS-linked protein aggregates.
Similar content being viewed by others
Acknowledgements
We would like to thank the Imaging Facility at the Center for Life Nano & NeuroScience, Istituto Italiano di Tecnologia@Rome and the Microscopy Facility, Department of Biology and Biotechnologies “C. Darwin”, Sapienza University of Rome (Sapienza Research Infrastructure) for technical support on image acquisition; Dr Sara Tavella (IGM-CNR, Pavia), Dr Ubaldo Gioia (IGM-CNR, Pavia), Dr Sara Sepe (IFOM, Milan) and Dr Fabrizio d’Adda di Fagagna (IGM-CNR, Pavia, IFOM, Milan) for their helpful advice and Dr Ornella Brandi (IGM-CNR) for generating the A382T TDP-43 and I383V TDP-43 constructs and for observing for the first time that cells with TDP-43 CIs have reduced level of total CHK1 protein, suggesting one initial hypothesis of this study. SM is supported by: Istituto Universitario di Studi Superiori (IUSS, Pavia, Itay); Istituto Superiore di Sanità RIPREI2023_7c8ae10d783c; Progetto AriSLA 2021 “DDR & ALS”; POR FESR 2014–20 Regione Lombardia (InterSLA project) (DSB.AD004.294). ES and OP are supported by Italian Ministry of Health (Ricerca Corrente 2025 - 2027). SDU and VS are supported by ERC-2019-SyG 855923-ASTRA. AG is supported by: POR FESR 2014-2020 Regione Lombardia (InterSLA project) (DSB.AD004.294); Italian Association for Cancer Research AIRC Investigator Grant IG2022-27833. NDA is supported by: Fondazione AriSLA ETS (Fondazione di Ricerca per la SLA ETS), SwitchALS project; #NEXTGENERATIONEU (NGEU) and founded by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006) – A Multiscale Integrated Approach to the Study of the Nervous System in Health and Disease (DN. 1553 11.10.2022). AR is supported by PRIN 2022 (2022R7LH5T). MC is supported by: Fondazione AriSLA ETS (Fondazione di ricerca per la SLA ETS), SwitchALS project; CNR (DBA.AD005.225-NUTRAGE-FOE2021). SS is supported by the Associazione Italiana per la Ricerca sul Cancro Investigator Grant IG-2020-24316; MUR PRIN 2017 (2017KSZZJW), MUR/PNRR Next Generation EU PRIN 2022 (2022JA8JY5), NUTRAGE CNR project FOE-2021 DBA.AD005.225. MM is supported by Fondo Ricerca Ateneo 2024 (n. RG12419107CD28D5) Università Sapienza di Roma. SF is supported by: AIRC Investigator Grant 2025 ID 32610; AriSLA full grant 2021 “DDR & ALS” 2016 “DDRNA &ALS”; PNRR-CN3 “National Center for Gene Therapy and Drugs based on RNA Technology”; Progetti di Ricerca di Interesse Nazionale (PRIN) 2017 (2017NWEXEP); PRIN 2020 (2020CXFL4T); PRIN 2022 (2022R7LH5T); POR FESR 2014-2020 Regione Lombardia (InterSLA project) (DSB.AD004.294); Progetto DONO ID6069058 “Collabora & Innova” Regione Lombardia; NUTRAGE CNR project FOE-2021 DBA.AD005.225.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
All activities that involve human subjects were conducted in accordance with the World Medical Association’s Declaration of Helsinki. The study design was examined by the ethical committee of the enrolling institutions (p-20180034329) (Approval date: 15/02/2021). Informed consent was obtained from all subjects involved in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Wei-Na Jin
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Modafferi, S., Silenzi, V., Garbelli, A. et al. Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems. Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-08603-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-026-08603-6


